Results 71 to 80 of about 5,593 (170)
CONTEXT: Whether Helicobacter pylori infection is a protective or predisposing factor for the development of gastroesophageal reflux disease remains controversial. The most virulent strains, such as those expressing the cytotoxin-associated gene A (CagA),
Carlos Alexandre Gonçalves Batista +5 more
doaj +1 more source
Efficacy of esomeprazole at treatment of patients with gastroesophageal reflux disease
Aim of review. To present literature data on efficacy and safety of esomeprazole for the treatment of gastroesophageal reflux disease (GERD). Summary. GERD is one of the most widespread chronic diseases.
Yu. V. Yevsyutina
doaj +1 more source
Incidence of Gastroesophageal Reflux Disease Postsleeve Surgery in Bariatric Patients [PDF]
Background: The laparoscopic Roux-en-Y gastric bypass is currently suggested as the operation of choice for cases with severe obesity and gastroesophageal reflux disease (GERD) since it has been correlated with acceptable GERD control in both short ...
doaj +1 more source
Background/Aims: Our aim is to assess the relationship between interleukin 1β (IL-1 β), (-511,-31 alleles), interleukin 1RN (IL-RN), Helicobacter pylori (HP) status and gastroesophageal reflux disease (GERD) diagnosed by pH monitoring in the ...
Gülhan Akçil +7 more
doaj +1 more source
Effect of Roux-en-Y gastric bypass in the control of erosive esophagitis
Background: Gastroesophageal reflux disease (GERD) is a multifactorial disease associated with environmental and genetic factors. Obesity is among the risk factors for its development, which also correlates with an increase in severity of clinical ...
Antônio Benincá Albuquerque +11 more
doaj
Background/AimsInterobserver variation by experience was documented for the diagnosis of esophagitis using the Los Angeles classification. The aim of this study was to evaluate whether interobserver agreement can be improved by higher levels of ...
doaj +1 more source
Delayed release dexlansoprazole in the treatment of GERD and erosive esophagitis
Eric T Wittbrodt1, Charles Baum2, David A Peura31Takeda Pharmaceuticals North America, Inc., 2Takeda Pharmaceuticals International, Inc., Deerfield, IL, USA; 3University of Virginia, School of Medicine, Charlottesville, VA, USAAbstract: Although proton ...
Eric T Wittbrodt +2 more
doaj
Systemic immune response at gastroesophageal reflux disease
Aim of investigation. To characterize the systemic immune response at patients various forms of gastroesophageal reflux disease (GERD).Material and methods. Overall 45 patients with GERD and 10 healthy volunteers were included in prospective study.
Yu. V. Yevsyutina +4 more
doaj
Alginates in the treatment of postgastroresection reflux esophagitis
Aim. To evaluate the efficacy of alginates in the treatment of postgastroresection reflux esophagitis. Subjects and methods. Thirty-four post-Billroth II distal gastrectomy patients with reflux esophagitis and without erosive and ulcerative lesions of ...
O B Ianova, V A Kim, E V Treĭman
doaj

